1 / 8

lipid-lowering-drugs-market

Theu00a0global lipid lowering drugs market size is accounted to grow at a significant CAGR of 2.6% during the forecast period and expected to reach over USD 25 billion by 2027. The rising prevalence of hyperlipidemia in the young adult population worldwide primarily drives the lipid lowering drugs market growth. Promising drug pipeline and effective implementation of treatment guidelines for lowering blood cholesterol levels further accentuate the market growth.

Download Presentation

lipid-lowering-drugs-market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Global Lipid Lowering Drugs Market Global Lipid Lowering Drugs Market by Drug Class, by Distribution Channel, by Region, Size, Share, Growth, Global Trends, Industry Analysis and Forecast to 2027 To know more about this study, request a free sample report @ https://www.researchcorridor.com/request-sample/?id=145651

  2. Global Lipid Lowering Drugs Market Market Synoposis: Theglobal lipid lowering drugs market size is accounted to grow at a significant CAGR of 2.6% during the forecast period and expected to reach over USD 25 billion by 2027. The rising prevalence of hyperlipidemia in the young adult population worldwide primarily drives the lipid lowering drugs market growth. Promising drug pipeline and effective implementation of treatment guidelines for lowering blood cholesterol levels further accentuate the market growth.

  3. Global Lipid Lowering Drugs Market Research Methoddology:

  4. Global Lipid Lowering Drugs Market Global Lipid Lowering Drugs Market Segmentation: By Drug Class: • Statins • Bile Acid Sequestrants • Cholesterol Absorption Inhibitors • Fibric Acid Derivatives • PCSK9 Inhibitors • Combination • Others By Distribution Channel: • Hospital Pharmacy • Retail Pharmacy • Others

  5. Global Lipid Lowering Drugs Market Global Lipid Lowering Drugs Market Segmentation: By Region: • North America • Europe • Asia Pacific • Latin America • Middle East & Africa

  6. Global Lipid Lowering Drugs Market By Region:

  7. Global Lipid Lowering Drugs Market List of Key Companies: • AstraZeneca, Plc. • Merck Co., Inc. • Pfizer, Inc. • Amgen, Inc. • Sanofi • AbbVie, Inc. • Novartis AG. • Bristol-Myers Squibb & Company • Lupin Pharmaceuticals, Inc. • Aralez Pharmaceuticals, Inc.

  8. Global Lipid Lowering Drugs Market Media Contact: Company Name: Research CorridorContact Person: Mr. Vijendra SinghEmail: sales@researchcorridor.comContact no: +1 520-686-7060 Follow Us:

More Related